Follow-up study after fecal microbiota transplantation in combination with antibiotics for patients with active ulcerative colitis

Follow-up study after fecal microbiota transplantation in combination with antibiotics for patients with active ulcerative colitis - Follow-up study after A-FMT for active UC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051295

Enrollment

Registered

2023-06-11

Start date

2023-06-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who participated in the preceding specific clinical study " Fecal microbiota transplantation in combination with antibiotics for patients with active ulcerative colitis".

Exclusion criteria

Exclusion criteria: Patients deemed unsuitable as subjects by the principal investigator

Design outcomes

Primary

Measure	Time frame
The following symptom scores will be assessed at baseline, 3, 6, 9, and 12 months Stool frequency, stool characteristics, percentage of bloody stools, presence of mucus, nocturnal diarrhea, fecal incontinence, abdominal pain, physical condition related to enteritis (self-assessment), tenderness, fever (>38 degree celsius), diarrhea, intestinal complications (e.g. arthritis)	—

Countries

Japan

Contacts

Public ContactKei Nomura

Juntendo University Hospital Department of Gastroenterology

ke-nomura@juntendo.ac.jp03-3813-3111

Outcome results